Home > Insider Trading > Filing (0001790300-21-000010)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1427570	Reshape Lifesciences Inc.	RSLS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1181166	Thomas Stankovich	1001 Calle Amanecer San Clemente CA 92673	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $0.001 Par Value Per Share	Acquisiton	2021-07-22	282,382	$0.00	315,995	No	4	A	Direct
Common Stock, $0.001 Par Value Per Share	Acquisiton	2021-07-22	90,362	$0.00	406,357	No	4	A	Direct
Common Stock, $0.001 Par Value Per Share	Disposition	2021-09-10	48,366	$2.89	357,991	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	A	Direct
No	4	S	Direct

Footnotes

These shares will vest and be issued with respect to 123,542 shares on July 22, 2021 and the remaining shares vesting monthly thereafter for 36 months pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan.
These shares will vest and be issued monthly over 36 months beginning on July 22, 2021 pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan.
These shares were sold to cover taxes in connection with the vesting of restricted stock units.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.88 to $2.90, inclusive. The Reporting Person undertakes to provide to ReShape Lifesciences Inc., any security holder of ReShape Lifesciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.